Genome Editing in Cardiovascular Diseases

Genome editing is a powerful tool to study specific mutations or genes involved in the development and progression of cardiovascular disease. Discover the latest research on Genome Editing in Cardiovascular Disease here.

April 18, 2021

CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.

Cancer Gene Therapy
Raoud MarayatiElizabeth A Beierle
April 17, 2021

Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell development.

Luyi TianShalin H Naik
April 16, 2021

How orthodontic research can be enriched and advanced by the novel and promising evolutions in biomedicine.

Journal of Orthodontics
Mohamed G HassanAthanasios E Athanasiou
April 16, 2021
Open Access

A stress-free strategy to correct point mutations in patient iPS cells.

Stem Cell Research
Jingli CaiLorraine Iacovitti
April 16, 2021

Genetic therapies for the first molecular disease.

The Journal of Clinical Investigation
Phillip A DoerflerMitchell J Weiss
April 16, 2021
Open Access

CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells.

STAR Protocols
Sabrina GhettiLuca L Fava
April 15, 2021

Current applications of SCNT in advanced breeding and genome editing in livestock.

Reproduction : the Official Journal of the Society for the Study of Fertility
Cesare Galli, Giovanna Lazzari
April 14, 2021
Open Access

Constitutive depletion of Slc34a2/NaPi-IIb in rats causes perinatal mortality.

Scientific Reports
Eva Maria Pastor-ArroyoCarsten A Wagner
April 14, 2021

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.

Nature Genetics
Daichi InoueOmar Abdel-Wahab
April 14, 2021
Open Access

Base editing repairs an SGCA mutation in human primary muscle stem cells.

JCI Insight
Helena EscobarSimone Spuler
April 13, 2021
Open Access

Comprehensive analysis of prime editing outcomes in human embryonic stem cells

BioRxiv : the Preprint Server for Biology
O. HabibSangsu Bae
April 12, 2021
Open Access

Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy

BioRxiv : the Preprint Server for Biology
N.-V. MohamedThomas M. Durcan
April 12, 2021
Open Access

Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics.

Frontiers in Pharmacology
Pamela Velázquez-DíazYang Zhou
April 11, 2021

Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing.

James K NuñezJonathan S Weissman
April 10, 2021
Open Access

Generation of Murine Bone Marrow and Fetal Liver Chimeras.

Current Protocols
Stéphane ChappazBenjamin T Kile
April 8, 2021
Open Access

Zbp1-positive cells are osteogenic progenitors in periodontal ligament.

Scientific Reports
Tsugumi UedaShinya Murakami
April 10, 2021

The Genetic Basis of Reporter Mouse Strains.

Advances in Experimental Medicine and Biology
Gyeong-Nam Kim, Young Hoon Sung

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing studies have shed light on the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). This feed follows papers using RNA sequencing technologies in Alzheimer's research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

© 2021 Meta ULC. All rights reserved